List of Tables
Table 1. Global Biosimilars Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Biosimilars Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Biosimilars Market Competitive Situation by Manufacturers in 2023
Table 4. Global Biosimilars Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Biosimilars Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Biosimilars Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Biosimilars Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Biosimilars Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biosimilars, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biosimilars, Product Type & Application
Table 12. Global Key Manufacturers of Biosimilars, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biosimilars Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Biosimilars Sales by Region (2019-2024) & (K Units)
Table 18. Global Biosimilars Sales Market Share by Region (2019-2024)
Table 19. Global Biosimilars Sales by Region (2025-2030) & (K Units)
Table 20. Global Biosimilars Sales Market Share by Region (2025-2030)
Table 21. Global Biosimilars Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Biosimilars Revenue Market Share by Region (2019-2024)
Table 23. Global Biosimilars Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Biosimilars Revenue Market Share by Region (2025-2030)
Table 25. North America Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Biosimilars Sales by Country (2019-2024) & (K Units)
Table 27. North America Biosimilars Sales by Country (2025-2030) & (K Units)
Table 28. North America Biosimilars Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Biosimilars Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Biosimilars Sales by Country (2019-2024) & (K Units)
Table 32. Europe Biosimilars Sales by Country (2025-2030) & (K Units)
Table 33. Europe Biosimilars Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Biosimilars Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Biosimilars Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Biosimilars Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Biosimilars Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Biosimilars Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Biosimilars Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Biosimilars Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Biosimilars Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Biosimilars Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Biosimilars Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Biosimilars Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Biosimilars Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Biosimilars Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Biosimilars Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Biosimilars Sales (K Units) by Type (2019-2024)
Table 51. Global Biosimilars Sales (K Units) by Type (2025-2030)
Table 52. Global Biosimilars Sales Market Share by Type (2019-2024)
Table 53. Global Biosimilars Sales Market Share by Type (2025-2030)
Table 54. Global Biosimilars Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Biosimilars Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Biosimilars Revenue Market Share by Type (2019-2024)
Table 57. Global Biosimilars Revenue Market Share by Type (2025-2030)
Table 58. Global Biosimilars Price (USD/Unit) by Type (2019-2024)
Table 59. Global Biosimilars Price (USD/Unit) by Type (2025-2030)
Table 60. Global Biosimilars Sales (K Units) by Application (2019-2024)
Table 61. Global Biosimilars Sales (K Units) by Application (2025-2030)
Table 62. Global Biosimilars Sales Market Share by Application (2019-2024)
Table 63. Global Biosimilars Sales Market Share by Application (2025-2030)
Table 64. Global Biosimilars Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Biosimilars Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Biosimilars Revenue Market Share by Application (2019-2024)
Table 67. Global Biosimilars Revenue Market Share by Application (2025-2030)
Table 68. Global Biosimilars Price (USD/Unit) by Application (2019-2024)
Table 69. Global Biosimilars Price (USD/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Biosimilars Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Novartis Biosimilars Product
Table 79. Novartis Recent Developments/Updates
Table 80. Biocon Corporation Information
Table 81. Biocon Description and Business Overview
Table 82. Biocon Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Biocon Biosimilars Product
Table 84. Biocon Recent Developments/Updates
Table 85. Biogen Corporation Information
Table 86. Biogen Description and Business Overview
Table 87. Biogen Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Biogen Biosimilars Product
Table 89. Biogen Recent Developments/Updates
Table 90. Fresenius Kabi AG Corporation Information
Table 91. Fresenius Kabi AG Description and Business Overview
Table 92. Fresenius Kabi AG Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Fresenius Kabi AG Biosimilars Product
Table 94. Fresenius Kabi AG Recent Developments/Updates
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Boehringer Ingelheim Biosimilars Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Merck KgaA Corporation Information
Table 101. Merck KgaA Description and Business Overview
Table 102. Merck KgaA Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Merck KgaA Biosimilars Product
Table 104. Merck KgaA Recent Developments/Updates
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Mylan Biosimilars Product
Table 109. Mylan Recent Developments/Updates
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Eli Lilly Biosimilars Product
Table 114. Eli Lilly Recent Developments/Updates
Table 115. Teva Pharmaceutical Corporation Information
Table 116. Teva Pharmaceutical Description and Business Overview
Table 117. Teva Pharmaceutical Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Teva Pharmaceutical Biosimilars Product
Table 119. Teva Pharmaceutical Recent Developments/Updates
Table 120. Dr. Reddy's Laboratories Corporation Information
Table 121. Dr. Reddy's Laboratories Description and Business Overview
Table 122. Dr. Reddy's Laboratories Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Dr. Reddy's Laboratories Biosimilars Product
Table 124. Dr. Reddy's Laboratories Recent Developments/Updates
Table 125. Amgen Corporation Information
Table 126. Amgen Description and Business Overview
Table 127. Amgen Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Amgen Biosimilars Product
Table 129. Amgen Recent Developments/Updates
Table 130. Celltrion Corporation Information
Table 131. Celltrion Description and Business Overview
Table 132. Celltrion Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Celltrion Biosimilars Product
Table 134. Celltrion Recent Developments/Updates
Table 135. Samsung Biologics Corporation Information
Table 136. Samsung Biologics Description and Business Overview
Table 137. Samsung Biologics Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Samsung Biologics Biosimilars Product
Table 139. Samsung Biologics Recent Developments/Updates
Table 140. Roche Corporation Information
Table 141. Roche Description and Business Overview
Table 142. Roche Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Roche Biosimilars Product
Table 144. Roche Recent Developments/Updates
Table 145. Probiomed Corporation Information
Table 146. Probiomed Description and Business Overview
Table 147. Probiomed Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Probiomed Biosimilars Product
Table 149. Probiomed Recent Developments/Updates
Table 150. Apotex Corporation Information
Table 151. Apotex Description and Business Overview
Table 152. Apotex Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Apotex Biosimilars Product
Table 154. Apotex Recent Developments/Updates
Table 155. Chong Kun Dang Corporation Information
Table 156. Chong Kun Dang Description and Business Overview
Table 157. Chong Kun Dang Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. Chong Kun Dang Biosimilars Product
Table 159. Chong Kun Dang Recent Developments/Updates
Table 160. JCR Pharmaceuticals Corporation Information
Table 161. JCR Pharmaceuticals Description and Business Overview
Table 162. JCR Pharmaceuticals Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 163. JCR Pharmaceuticals Biosimilars Product
Table 164. JCR Pharmaceuticals Recent Developments/Updates
Table 165. Gan & Lee Pharmaceuticals Corporation Information
Table 166. Gan & Lee Pharmaceuticals Description and Business Overview
Table 167. Gan & Lee Pharmaceuticals Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 168. Gan & Lee Pharmaceuticals Biosimilars Product
Table 169. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 170. Gedeon Richter Corporation Information
Table 171. Gedeon Richter Description and Business Overview
Table 172. Gedeon Richter Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 173. Gedeon Richter Biosimilars Product
Table 174. Gedeon Richter Recent Developments/Updates
Table 175. Biocad Corporation Information
Table 176. Biocad Description and Business Overview
Table 177. Biocad Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 178. Biocad Biosimilars Product
Table 179. Biocad Recent Developments/Updates
Table 180. Coherus Bioscience Corporation Information
Table 181. Coherus Bioscience Description and Business Overview
Table 182. Coherus Bioscience Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 183. Coherus Bioscience Biosimilars Product
Table 184. Coherus Bioscience Recent Developments/Updates
Table 185. Stada Arzneimittel AG Corporation Information
Table 186. Stada Arzneimittel AG Description and Business Overview
Table 187. Stada Arzneimittel AG Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 188. Stada Arzneimittel AG Biosimilars Product
Table 189. Stada Arzneimittel AG Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Biosimilars Distributors List
Table 193. Biosimilars Customers List
Table 194. Biosimilars Market Trends
Table 195. Biosimilars Market Drivers
Table 196. Biosimilars Market Challenges
Table 197. Biosimilars Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biosimilars
Figure 2. Global Biosimilars Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Biosimilars Market Share by Type in 2023 & 2030
Figure 4. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure 5. Recombinant Glycosylated Proteins Product Picture
Figure 6. Global Biosimilars Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Biosimilars Market Share by Application in 2023 & 2030
Figure 8. Oncology
Figure 9. Blood Disorders
Figure 10. Growth Hormonal Deficiency
Figure 11. Chronic and Autoimmune Disorders
Figure 12. Others
Figure 13. Global Biosimilars Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Biosimilars Market Size (2019-2030) & (US$ Million)
Figure 15. Global Biosimilars Sales (2019-2030) & (K Units)
Figure 16. Global Biosimilars Average Price (USD/Unit) & (2019-2030)
Figure 17. Biosimilars Report Years Considered
Figure 18. Biosimilars Sales Share by Manufacturers in 2023
Figure 19. Global Biosimilars Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Biosimilars Players: Market Share by Revenue in 2023
Figure 21. Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Biosimilars Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Biosimilars Sales Market Share by Country (2019-2030)
Figure 24. North America Biosimilars Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Biosimilars Sales Market Share by Country (2019-2030)
Figure 28. Europe Biosimilars Revenue Market Share by Country (2019-2030)
Figure 29. Germany Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Biosimilars Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Biosimilars Revenue Market Share by Region (2019-2030)
Figure 36. China Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Biosimilars Sales Market Share by Country (2019-2030)
Figure 46. Latin America Biosimilars Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Biosimilars Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Biosimilars Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Biosimilars by Type (2019-2030)
Figure 56. Global Revenue Market Share of Biosimilars by Type (2019-2030)
Figure 57. Global Biosimilars Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Biosimilars by Application (2019-2030)
Figure 59. Global Revenue Market Share of Biosimilars by Application (2019-2030)
Figure 60. Global Biosimilars Price (USD/Unit) by Application (2019-2030)
Figure 61. Biosimilars Value Chain
Figure 62. Biosimilars Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed